Immutep (IMMP) Gross Margin (2015)

Immutep's (IMMP) quarterly Gross Margin came in at 370.33% in Q2 2015.

Immutep (IMMP) Gross Margin (2015) Analysis & Trends

Immutep (IMMP) has 1 years of Gross Margin data on file, last reported at 370.33% in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Vertex Pharmaceuticals	138.57 Bn	130.72 Bn	2.84 Bn	85.33%
2	Regeneron Pharmaceuticals	85.99 Bn	77.99 Bn	3.93 Bn	91.59%
3	Argenx Se	65.00 Bn	59.82 Bn	1.37 Bn	90.43%
4	Moderna	56.27 Bn	51.13 Bn	52.00 Mn	35.86%
5	BeOne Medicines	42.00 Bn	36.90 Bn	1.53 Bn	89.76%
6	Alnylam Pharmaceuticals	31.60 Bn	28.29 Bn	992.69 Mn	76.90%
7	BioNTech SE	27.68 Bn	9.29 Bn	668.28 Mn	63.27%
8	Insmed	27.43 Bn	26.27 Bn	358.27 Mn	84.20%
9	Royalty Pharma	27.34 Bn	26.51 Bn	-	-
10	Immutep	56.46 Mn	-8.63 Mn	-	-

Download Data

Date	Value
Jun 30, 2015	-370.33%